Portfolios

Worked with a ventilator technology scale up to source and develop suitable M&A partners for the business. This involved working with global industry strategics to determine product fit and suitable deal structure.

Ongoing support as the Fractional COO to build out strategic initiatives and provide direction on operations needs and partner development.

Engagement was provided with key investors for a number of MedTech start ups and early stage companies to support company funding requirements. These rounds included Seed, Series A and Series B. Amounts ranged from 2.5 Million USD to 50 Million USD.

Services were provided to support M&A activity during development of the biomedical division. This division provided service to the company’s imaging products and was an initiative directed by the US head office. Activities included identification of suitable targets, size up and due diligence on each target and involvement in initial acquisition discussions with senior management. The results and outcome were well received and the opportunity for further work was discussed.

Services were provided to support a novel diagnostic assay for Alzheimer’s Disease at market with efforts focused on business development. marketing and partnerships. Introduced the company to industry partners and engaged in active discussions with potential partners and company representatives. Also worked closely with the product development lead.

Services were provided to support both final product development and market assessment regarding suitable industry partners. The product was an IVD and was initially launched in major centers in the US and Canada. The distributor was subsequently acquired and the project was completed.

Services were provided to support Series A fundraising efforts for a novel urological device. Activities included outreach to targeted investors, sharing of company material and information, deal cultivation with interested investors and follow-up discussions with investors and senior management (CEO).